About Synchem
Synchem is a Healthcare company based in Elk Grove Village (United States) founded in 1997 by Daniel Fang and Ze-Qi Xu, and was acquired by Formosa Laboratories in June 2024. Custom organic synthesis, medicinal chemistry, and CMC services are provided. Its chief executive, as recorded, is W Paul Mar. Synchem offers products and services including Process Development, Bioconjugation, Peptide Synthesis, Small Molecule Synthesis, and Catalog Chemicals. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Medicinal Chemistry. Its legal entity is SynChem, Inc.
Company details
Synchem was established in 1997 in Elk Grove Village, United States, as a provider of custom organic synthesis, medicinal chemistry, and CMC services under cGMP conditions. Operations focus on supporting pharmaceutical and biotech clients through project completion, with over 4,500 initiatives delivered. The company is headquartered near Chicago and serves multinational firms in the life sciences sector.
- Headquarters Elk Grove Village, United States
- Founders Daniel Fang, Ze-Qi Xu
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website synchem.com
- Social LinkedIn
- Acquired by Formosa Laboratories (Jun 2024)
- Legal Name Synchem, Inc.
- Investors
- Acquired byFormosa Laboratories
(Jun 2024)
Associated legal entities of Synchem
Synchem is associated with 3 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Synchem Distributors Pvt Ltd CIN U51397MP1990PTC005763 | Active | 02 Apr 1990 | Sagar, Madhya Pradesh | ₹23.1 Cr | 2 | View details | |
| Synchem Pharmaceuticals Private Limited CIN U24239MP2000PTC051978 | Active | 19 Apr 2000 | Indore, Madhya Pradesh | ₹53.6 Cr | 159 | 3 | View details |
| Synchem Laboratories Private Limited CIN U24231GJ1996PTC030191 | Active | 12 Jul 1996 | Vadodara, Gujarat | ₹25.3 Cr | 2 | View details |
Products & Services of Synchem
Synchem offers a comprehensive portfolio of products and services, including Process Development, Bioconjugation, Peptide Synthesis, Small Molecule Synthesis, and Catalog Chemicals.
Provides scalable solutions for chemical efficiency in pharmaceuticals.
Enables precision linking for advanced therapeutics development.
Tailors peptides for therapeutic and innovative applications.
Focuses on precision in complex molecular design and processes.
Offers ADC-related building blocks for research and development.
Investors in Synchem
Synchem has secured backing from 1 investor. Prominent investors backing the company include Formosa Laboratories.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
APIs and pharmaceutical intermediates are manufactured by Formosa Laboratories. | 1996 | formosalab.com | Taoyuan City, Taiwan |
Investor details for Synchem
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Synchem
The boards of the 3 registered companies of Synchem currently have 7 directors; the longest-serving is Rajendra Kumar Jain, appointed in 1990. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rajendra Kumar Jain DIN 01895777 | Director | 02 Apr 1990 | 36 yrs 6 mo | Synchem Distributors Pvt Ltd |
| Jinendra Kumar Jain DIN 00353133 | Whole-time director | 12 Jul 1996 | 30 yrs 3 mo | Synchem Laboratories Private Limited |
| Arvindr Kumar Jain DIN 00353191 | Whole-time director | 12 Jul 1996 | 30 yrs 3 mo | Synchem Laboratories Private Limited |
| Prdam Kumar Jain DIN 01014247 | Director | 01 Apr 2000 | 26 yrs 6 mo | Synchem Distributors Pvt Ltd |
| Dinesh Kumar Jain DIN 01903486 | Whole-time director | 19 Apr 2000 | 26 yrs 6 mo | Synchem Pharmaceuticals Private Limited |
| Dharmendra Jain DIN 00435551 | Managing Director | 19 Apr 2000 | 26 yrs 6 mo | Synchem Pharmaceuticals Private Limited |
| Manish Jain DIN 01518865 | Whole-time director | 01 Jun 2007 | 19 yrs 4 mo | Synchem Pharmaceuticals Private Limited |
People of Synchem
3 people are tracked at Synchem (3 in leadership).
| Name | Role | Group |
|---|---|---|
Daniel Fang | Co-Founder & COO | Leadership |
Ze-Qi Xu | Co-Founder & CSO | Leadership |
W Paul Mar | CEO | Leadership |
Complete people profiles for Synchem
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Synchem
Figures of Synchem Laboratories Private Limited, the primary company behind Synchem, for FY 2024. Revenue was ₹25.30 Cr (+7% year on year). Net profit was ₹3.37 Cr (13% margin). EBITDA was ₹5.23 Cr (21% margin). Revenue has grown at a compounded annual rate of +28% over three years and +15% over five years.
- ₹25.30 CrRevenue · FY 2024 · +7% YoY
- ₹3.37 CrNet profit · 13% margin
- ₹5.23 CrEBITDA · 21% margin
- ₹7 LakhPaid-up capital
- +28%Revenue CAGR, 3 years
- +15%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Synchem Laboratories Private Limited are on its company page.
Detailed financial statements for Synchem
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Synchem
2 dated milestones of Synchem across 27 years, from founding to its latest funding, stage changes and deals.
- Founded Synchem is founded.
- Exit Acquired by Formosa Laboratories.
Web traffic of Synchem
The website of Synchem (synchem.com) receives about 2.6K visits a month.
- Monthly visits2.6K
▲ 14% vs previous month
Websites whose visitors overlap most with Synchem. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| amsyn.com | 100% | 4.1K | View details | ||
| presschem.com | 84% | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Synchem (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Synchem
Complete news archive for Synchem
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Synchem
Synchem was founded in 1997.
Synchem is headquartered in Elk Grove Village, United States. It is registered at Elk Grove Village, Illinois, United States.
W Paul Mar is the CEO of Synchem, as recorded in our data.
Synchem was established in 1997 in Elk Grove Village, United States, as a provider of custom organic synthesis, medicinal chemistry, and CMC services under cGMP conditions. Operations focus on supporting pharmaceutical and biotech clients through project completion, with over 4,500 initiatives delivered. The company is headquartered near Chicago and serves multinational firms in the life sciences sector.
Synchem offers Process Development, Bioconjugation, Peptide Synthesis, Small Molecule Synthesis, and Catalog Chemicals.
Synchem has 1 investor. Key investors include Formosa Laboratories.
Synchem is associated with 3 legal entities: Synchem Laboratories Private Limited, Synchem Pharmaceuticals Private Limited, Synchem Distributors Pvt Ltd.
Yes. Synchem was acquired by Formosa Laboratories in June 2024.
The legal entities of Synchem currently have 7 directors, including Jinendra Kumar Jain, Arvindr Kumar Jain, Dinesh Kumar Jain and others.

